CLA Based Functional Foods: Evidence, Delivery & Dose?

29-30th June 2006

Moorepark Food Research Centre, Teagasc, Fermoy, Co. Cork, Ireland.

Brochure is available to download in Acobat PDF (525kb) format.

Introduction

A number of studies have shown that dietary conjugated linoleic acid (CLA) reduces mammary tumorigenesis including metastasis, with relatively low concentrations required to exert these effects. This symposium will take a global view of CLA as a healthpromoting bioactive agent in food, and the main questions that will be addressed are:

1. Is there sufficient clinical evidence to support the commercialization of CLA based Functional Foods?
2. Is the technology sufficiently robust to deliver stable CLA enriched Functional Foods?
3. What amount is required for efficacy?
4. What are the legislative and labelling issues regarding CLA based Functional Foods?

Scientific Contact:

Dr. Catherine Stanton,
Moorepark Food Research Centre,
Teagasc, Fermoy, Co. Cork, Ireland.

Tel: +353 25 42606
Fax: 353 25 42340
Email: catherine.stanton@teagasc.ie

Secretary:

Lynn Fahy,
Moorepark Food Research Centre,
Teagasc, Fermoy, Co. Cork, Ireland.

Tel: +353 25 42634
Fax: +353 25 42340
Email: lynn.fahy@teagasc.ies